News

Core vendors seek to eliminate barriers in bank-fintech partnerships

The Milford Bank is a 149-year-old community institution in Connecticut trying to attract a younger audience. But there are limits to how extensively it can enhance its technological capabilities in-house or research, test and integrate products from potential fintech partners. With the help of Fiserv, its core provider, the $550 million-asset bank incorporated into its offerings the services of FutureFuel.io, which helps users manage their student debt. Fiserv has been quietly engineering connections between its bank clients and fintechs […]

The donation of sight

North Country Association for the Visually Impaired Executive Director Amy Kretser tries on a pair of Tina Leonard’s eSight glasses on Nov. 18. Leonard, a Lake Placid real estate broker who died in September at the age of 63, used the $10,000 glasses for a short time until she lost all of her sight. Kretser isn’t sure exactly how the eSight glasses will be used. Perhaps they will be a “demo” model for people who are visually impaired to […]

What will tomorrow’s Covid-19 vaccines be like?

The first generation of Covid-19 vaccines was developed in record time. But now scientists have grander plans – for more potent immunity, easier transport, and mutation-proofing…
While Zion, an entrepreneur and chief executive of a small start-up called Akston Biosciences, was personally relieved that the tide was turning against the global pandemic, he faced the unenviable task of trying to convince his employees that their hard graft had not been in vain.
Read more >>

ZetrOZ Systems Expands Patient Access for Sustained Acoustic Medicine Treatment

ZetrOZ’s sam® is the only FDA-cleared, long-duration, home-use, ultrasound treatment system, with over 30 peer-reviewed studies showing it effectively increases nutrient transport, relieves pain, restores function, and returns patients back to work, sports and other daily activities. Its continuous ultrasound therapy promotes injury healing to deep tissue by inhibiting inflammation and increasing the rate of tissue regeneration, angiogenesis, and nutrient exchange. sam® was designed for easy, long-term home use. Read more >>

Pyramid Biosciences’ $864 Million Licensing Deal

Clinical-stage biotechnology company Pyramid Biosciences, Inc. announced the development of a global licensing deal for two cancer therapies worth up to $846 million. The licensing agreement with South Korea-based biotechnology company Voronoi, Inc. will bring a novel monopolar spindle1 (MPS1) called VRN-08 and second undisclosed asset into Pyramid Bioscience’s portfolio of precision oncology therapeutics. MPS1 is involved in core-of-tumor cell division. The novel inhibitor VRN-08 selectively blocks this process, ultimately leading to tumor cell death. Founded in 2015, Waltham, […]

Groton biotech firm working on much-needed drug to treat stroke, brain injuries

A small drug development company that moved its headquarters from Cambridge, Mass., to the BioCT Innovations Commons on Shennecossett Road last year is aiming to have a huge impact on the treatment of strokes and brain injuries.
Co-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a phase one clinical trial of its leading drug candidate in the first half of 2022.
Read more >>

Wasabi Technologies and Nutanix Partner to Deliver Next-Gen Capacity Management and Analytics for Unstructured Data Storage

Wasabi Technologies, the hot cloud storage company, today announced that it has partnered with Nutanix, a leader in hybrid multicloud computing, to deliver a next-generation capacity management and analytics solution that meets the evolving needs for unstructured data storage. Through Nutanix Files supported integration of data tiering to Wasabi’s cloud object store, joint customers will be able to scale unstructured datasets on demand, deploy automated rules and triggers for efficient data management, and gain high-impact analytics and complete visibility […]

Immusoft Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)

Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M grant to support the development of its ISP-002 (for delivery of iduronate sulfatase) program in mucopolysaccharidosis type II (MPS II), an inherited disease for which patients have limited options. MPS II is a rare genetic disease in children, which […]

Regroup Mass Notification Honored with 2021 ‘ASTORS’ Homeland Security Award for Best Mass Notification System

Regroup Mass Notification (http://www.regroup.com) today announced it is the recipient of a 2021 ‘ASTORS’ Homeland Security Award from American Security Today for its mass notification solution. American Security Today’s Annual ‘ASTORS’ Awards is the preeminent U.S. Homeland Security Awards Program, and today in its Sixth Year, continues to recognize industry leaders of Physical and Border Security, Cybersecurity, Emergency Preparedness – Management and Response, Law Enforcement, First Responders, as well as federal, state and municipal government agencies in the acknowledgment […]